The activity of N-acetyl-β-D-hexosaminidase in serum and urine of patients with pancreatic cancer
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 3
Abstract
Background: N-acetyl-β-D-hexosaminidase (HEX) is lysosomal exoglycosidase (EC 3.2.1.52), which releases N-acetyloheksozoamines from non reducing ends of oligosaccharide chains of glycoconjungates (glycoproteins, glycolipids and proteoglycans). Determination of HEX activity in tissues and body fluids was applied in diagnostics of Tay-Sachs and Sandhoff’s, as well as, kidney and liver diseases. The aim of our work was to evaluate the activity of HEX in blood serum and urine of patients with pancreatic cancer, as a potential cancer marker. Material and methods: Blood and serum were taken from 7 patients (44-77 years old) with histopathologically confirmed adenocarcinoma of the pancreas, in I Department of General and Endocrinological Surgery, Medical University, Białystok, Poland, and 8 (22-31 years old) healthy volunteers. The activity of HEX was determined by Chatterjee et al method as modified by Zwierz et al. Amount of p-nitrophenol released from p-nitrophenyl-β-D-N-acetylglucosaminepyranoside (Sigma) was evaluated on microplate reader ELX800, BIO-TEK at 410 nm. The concentration of HEX activity was expressed in pKat/mL, and specific activity in pKat/mg protein. Protein in serum was determined by the biuret, and in urine by the Lowry method. Results: Concentration and specific of the HEX activity in serum of patients with pancreatic cancer were more than three limes higher than concentration and specific of HEX activity in serum of healthy persons (p
Authors and Affiliations
Sławomir Dariusz Szajda, Jadwiga Snarska, Fabian Kamiński, Katarzyna Siedlecka, Napoleon Waszkiewicz, Małgorzata Knaś, Krzysztof Zwierz
Keywords
Related Articles
- EP ID EP128765
- DOI -
- Views 64
- Downloads 0
Targeted therapy of colorectal cancer - state of the art
The recent development of drugs that target the key components of biologic pathways rendered an improvement in survival in colorectal cancer patients. Two monoclonal antibodies in particular, targeting vascular endotheli...
Plazmidowy wektor ekspresyjny kodujący receptor sFLT-1 (psFLT-1) ogranicza angiogenezę i wzrost guzów L1
Antyangiogenna terapia genowa wykorzystuje geny kodujące białka ograniczające powstawanie nowych naczyń krwionośnych. W wypadku chorób nowotworowych stosowanie preparatów genowych antyangiogennych sprowadza się do prób...
Gigantic retroperitoneal leiomyosarcoma - case report
Retroperitoneal leiomyosarcomas are very rare malignant neoplasms. They are built up of smooth muscle cells. They can be found beyond the retroperitoneal space in the uterus, the stomach, the intestines, the blood vessel...
Aktywność N-acetylo-β-heksozoaminidazy i jej izoenzymów w tkance nerki, w surowicy krwi i w moczu pacjentów z rakiem nerki
W Polsce nowotwór nerki, obejmujący 3–4 proc. wszystkich nowotworów złośliwych, stanowi trudny problem diagnostyczny. Rak nerki (najczęstszy nowotwór nerki u dorosłych) jest zwykle diagnozowany, gdy wystąpiły odległe prz...
Estimation of quality of life in patients after surgery for lung cancer
Introduction: Lung cancer is the biggest challenge to modern medicine. Lung cancer incidence and mortality remain at a constant very high level, in particular among men. About 20000 persons develop lung cancer and approx...